Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-19 Purchase | 2022-10-21 7:01 pm | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 15,000 | $5.32 | $79,800 | 15,000 (Direct) | View |
| 2021-08-06 Sale | 2021-08-10 8:00 pm | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 25,000 | $138.52 | $3,462,926 | 132,891 (Direct) | View |
| 2020-09-01 Sale | 2020-09-03 4:46 pm | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $92.26 | $1,107,068 | 156,410 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 4:20 pm | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $86.74 | $1,040,919 | 168,410 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-28 Option Award | 2024-08-29 4:15 pm | N/A 2034-08-28 | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:28 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:22 pm | N/A 2033-06-07 | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:25 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 35,235 | $0 | 35,235 (Direct) | View |
| 2022-07-05 Option Award | 2022-08-11 6:03 pm | N/A 2032-07-05 | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-08-06 Exercise | 2021-08-10 8:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 25,000 | $17.75 | 132,891 (Direct) | View |
| 2021-03-11 Exercise | 2021-08-10 8:00 pm | N/A 2027-11-21 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 25,000 | $0 | 132,891 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-29 5:39 pm | N/A 2031-06-14 | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 1,352 | $124.15 | 36,251 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 2,833 | $0 | 36,251 (Direct) | View |
| 2021-03-11 Option Award | 2021-03-12 5:50 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 34,360 | $0 | 36,251 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:48 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 11,666 | $0 | 11,666 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-03 4:46 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $17.75 | 156,410 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-03 4:46 pm | N/A 2027-11-21 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $0 | 156,410 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 4:20 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $17.75 | 168,410 (Direct) | View |
| 2017-11-13 Exercise | 2020-08-05 4:20 pm | N/A 2027-11-21 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 12,000 | $0 | 168,410 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-08 7:08 pm | N/A 2030-06-05 | Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 4:30 pm | N/A 2030-03-10 | CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer | 43,500 | $0 | 43,500 (Direct) | View |